DENVER– EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for unsedated endoscopy, today announced the signing of a distribution agreement with Micro-Tech Endoscopy USA, Inc. (“Micro-Tech”). The agreement, whereby Micro-Tech will distribute the EvoEndo® Single-Use Endoscopy System in the U.S., is expected to begin pending U.S. FDA 510(k) clearance.
EvoEndo’s system combines a sterile, single-use, flexible, ultra-slim gastroscope with virtual reality (VR) patient entertainment to allow the procedure to be performed safely in children and adults without anesthesia or sedation. EvoEndo’s system is currently pending U.S. FDA 510(k) clearance and not available for sale in the U.S.
Heather Underwood, Chief Executive Officer at EvoEndo, commented, “Routine upper endoscopic procedures, many of which take minutes to perform, today, almost always involve anesthesia for pediatric patients or conscious sedation for adults, which places immense burdens on patients, hospitals, and facilities alike. We look forward to reducing these burdens by eliminating the complexities and high-costs associated with endoscopies and leveraging Micro-Tech’s U.S. distribution network to significantly expedite physician and patient access to our system once we receive clearance from the FDA.”
“EvoEndo’s transformative endoscopy system represents a notable innovation that we strive to deliver across our network,” said Chris Li, President of Micro-Tech Endoscopy USA. “We are excited to partner with EvoEndo’s team and look forward to bringing its system to hospitals, physicians and patients.”
